Nelotanserin
Overview[edit | edit source]
Nelotanserin is a selective 5-HT2A receptor antagonist that has been investigated for its potential use in the treatment of various neurological disorders. It is a member of the serotonin receptor antagonist class of drugs, which are known to modulate the effects of serotonin in the central nervous system.
Pharmacology[edit | edit source]
Nelotanserin acts primarily as an antagonist at the 5-HT2A receptor, a subtype of the serotonin receptor that is implicated in the regulation of mood, cognition, and perception. By blocking this receptor, nelotanserin may alter the effects of serotonin, potentially leading to therapeutic benefits in conditions such as insomnia, Parkinson's disease, and dementia with Lewy bodies.
Clinical Development[edit | edit source]
Nelotanserin has undergone various stages of clinical trials to assess its efficacy and safety in treating sleep disorders and neurodegenerative diseases. Initial studies have shown promise, particularly in improving sleep quality and reducing hallucinations in patients with Lewy body dementia. However, further research is needed to fully establish its clinical utility and safety profile.
Mechanism of Action[edit | edit source]
The primary mechanism of action of nelotanserin involves the blockade of the 5-HT2A receptor, which is thought to play a role in the modulation of neurotransmitter release and neural circuitry involved in sleep and cognition. By inhibiting this receptor, nelotanserin may help to stabilize neurotransmitter systems that are dysregulated in certain neurological conditions.
Potential Applications[edit | edit source]
Nelotanserin is being explored for its potential use in:
- Insomnia: By modulating serotonin pathways, nelotanserin may improve sleep onset and maintenance.
- Parkinson's disease: It may help alleviate non-motor symptoms such as sleep disturbances and psychosis.
- Dementia with Lewy bodies: Nelotanserin could reduce visual hallucinations and improve sleep quality.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
